ALC:NYE-Alcon AG (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 89.15

Change

-0.79 (-0.88)%

Market Cap

USD 46.01B

Volume

1.49M

Analyst Target

USD 65.36
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

-2.53 (-1.11%)

USD 65.91B
RMD ResMed Inc

-10.84 (-4.58%)

USD 34.14B
BAX Baxter International Inc

-0.71 (-1.94%)

USD 18.71B
AVTR Avantor Inc

-0.35 (-2.03%)

USD 11.92B
ATR AptarGroup Inc

-2.68 (-1.78%)

USD 10.16B
TFX Teleflex Incorporated

+0.35 (+0.25%)

USD 7.78B
STVN Stevanato Group SpA

-1.46 (-6.46%)

USD 5.88B
BLCO Bausch + Lomb Corp

-0.37 (-2.33%)

USD 5.64B
WRBY Warby Parker Inc

+0.53 (+2.61%)

USD 2.55B
INFU InfuSystems Holdings Inc

-0.07 (-1.24%)

USD 0.13B

ETFs Containing ALC

CHSR:XETRA UBS(Lux)Fund Solutions .. 5.08 % 0.00 %

-0.33 (-3.08%)

USD 0.17B
CHSRI:SW UBS ETF (CH) - MSCI Switz.. 5.01 % 0.00 %

-0.33 (-3.08%)

N/A
CHSRIA:SW UBS ETF (CH) MSCI Switzer.. 5.01 % 0.00 %

-0.41 (-3.08%)

N/A
CHSRII:SW UBS(Lux)Fund Solutions .. 4.98 % 0.00 %

-0.27 (-3.08%)

N/A
XSLI:SW Xtrackers SLI UCITS ETF 1.. 4.44 % 0.00 %

-4.70 (-3.08%)

USD 0.31B
SLICHA:SW UBS ETF (CH) – SLI® (C.. 4.43 % 0.00 %

-4.80 (-3.08%)

USD 32,912.73B
CSSLI:SW iShares SLI® ETF (CH) 4.42 % 0.00 %

-4.70 (-3.08%)

USD 0.67B
SMIEX:SW iShares SLI UCITS ETF (DE.. 4.41 % 0.00 %

-2.48 (-3.08%)

USD 5,933.96B
CBCH30:SW 3.78 % 0.00 %

N/A

N/A
C030:F Lyxor DJ Switzerland Tita.. 3.64 % 0.00 %

-3.12 (-3.08%)

USD 0.01B
XSMC:SW Xtrackers Switzerland UCI.. 3.16 % 0.00 %

-3.94 (-3.08%)

USD 0.50B
XSMI:SW Xtrackers Switzerland UCI.. 3.16 % 0.00 %

-3.20 (-3.08%)

USD 1.35B
SMICHA:SW UBS ETF (CH) – SMI® (C.. 3.16 % 0.00 %

-3.00 (-3.08%)

USD 17,142.72B
XSMI:XETRA Xtrackers Switzerland UCI.. 3.15 % 0.00 %

-4.28 (-3.08%)

N/A
CSSMI:SW iShares SMI® ETF (CH) 3.15 % 0.00 %

-3.18 (-3.08%)

USD 2.12B
ESRU:LSE Amundi Index Solutions - .. 3.12 % 0.00 %

-0.77 (-3.08%)

N/A
ACU7:XETRA Amundi Index Solutions - .. 3.11 % 0.00 %

-1.07 (-3.08%)

USD 0.13B
ESDU:LSE Amundi Index Solutions - .. 3.09 % 0.00 %

N/A

N/A
ESRG:LSE Amundi Index Solutions - .. 2.98 % 0.00 %

N/A

USD 2.06B
ESDG:LSE Amundi Index Solutions - .. 2.96 % 0.00 %

-60.00 (-3.08%)

USD 0.19B
FLSW Franklin FTSE Switzerland.. 2.87 % 0.09 %

-0.56 (-3.08%)

USD 0.06B
CHEUR:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
CHEURD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
CHUSD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

-0.39 (-3.08%)

N/A
CHUSDD:SW UBS(Lux)Fund Solutions .. 2.79 % 0.00 %

N/A

N/A
STWX:SW SPDR® MSCI Europe Health.. 2.75 % 0.00 %

-4.10 (-3.08%)

USD 0.72B
SXDPEX:SW iShares STOXX Europe 600 .. 2.61 % 0.00 %

N/A

USD 0.44B
SPICHA:SW UBS ETF (CH) – SPI® (C.. 2.52 % 0.00 %

-2.40 (-3.08%)

USD 131,872.43B
HEAE:LSE SPDR® MSCI Europe Health.. 2.50 % 0.00 %

-5.00 (-3.08%)

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.26 % 0.00 %

-0.34 (-3.08%)

N/A
VLED:F BNP Paribas Easy - Equity.. 2.10 % 0.00 %

-0.62 (-3.08%)

USD 0.07B
VLEU:F BNP Paribas Easy - Equity.. 2.10 % 0.00 %

-0.72 (-3.08%)

USD 0.05B
VLED:SW BNP Paribas Easy ESG Equi.. 2.10 % 0.00 %

N/A

USD 5.72M
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.10 % 0.00 %

-0.32 (-3.08%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.10 % 0.00 %

-0.06 (-3.08%)

N/A
EWL iShares MSCI Switzerland .. 0.00 % 0.47 %

-0.75 (-3.08%)

N/A
LNGR 0.00 % 0.50 %

N/A

N/A
RNDM 0.00 % 0.65 %

N/A

N/A
HLTH:LSE SPDR® MSCI Europe Health.. 0.00 % 0.00 %

-6.98 (-3.08%)

N/A
XSDR:LSE Xtrackers MSCI Europe Hea.. 0.00 % 0.00 %

-538.00 (-3.08%)

USD 0.23B
UC93:LSE UBS MSCI Switzerland 20/3.. 0.00 % 0.00 %

-58.00 (-3.08%)

USD 8.21M
UC94:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-49.00 (-3.08%)

USD 0.07B
EUSRI:PA Amundi Index Solutions - .. 0.00 % 0.00 %

-1.30 (-3.08%)

USD 2.09B
STW:PA SPDR® MSCI Europe Health.. 0.00 % 0.00 %

-7.45 (-3.08%)

USD 0.71B
DBXS:F 0.00 % 0.00 %

N/A

N/A
DXS0:F Xtrackers - SLI UCITS ETF 0.00 % 0.00 %

-4.95 (-3.08%)

N/A
DXSE:F Xtrackers Stoxx Europe 60.. 0.00 % 0.00 %

-4.25 (-3.08%)

N/A
EL4X:F Deka DAXplus Maximum Divi.. 0.00 % 0.00 %

N/A

N/A
EXI1:F iShares SLI UCITS ETF (DE.. 0.00 % 0.00 %

-6.42 (-3.08%)

N/A
EXV4:F 0.00 % 0.00 %

N/A

N/A
EXV5:F 0.00 % 0.00 %

N/A

N/A
MIVB:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
SPYH:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

-4.55 (-3.08%)

N/A
C030:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-5.14 (-3.08%)

USD 0.13B
DBXS:XETRA Xtrackers - Switzerland U.. 0.00 % 0.00 %

-4.28 (-3.08%)

USD 1.34B
DXS0:XETRA Xtrackers SLI UCITS ETF 1.. 0.00 % 0.00 %

-6.15 (-3.08%)

USD 0.26B
DXSE:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

-7.70 (-3.08%)

USD 0.14B
EXI1:XETRA iShares SLI UCITS ETF (DE.. 0.00 % 0.00 %

-4.04 (-3.08%)

USD 0.37B
EXV4:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

-3.72 (-3.08%)

USD 0.70B
MIVB:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-1.40 (-3.08%)

N/A
SPYH:XETRA SPDR® MSCI Europe Health.. 0.00 % 0.00 %

-7.10 (-3.08%)

N/A
1391:TSE 0.00 % 0.00 %

N/A

N/A
CHSPI:SW iShares Core SPI® ETF (C.. 0.00 % 0.00 %

-3.36 (-3.08%)

USD 4.02B
SW2CHA:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-0.48 (-3.08%)

USD 0.49B
SW2CHB:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-0.66 (-3.08%)

USD 1.75B
SW2UKD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

-0.46 (-3.08%)

USD 0.04B
SWICHA:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

-0.51 (-3.08%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

-0.87 (-3.08%)

USD 226,274.21B
CEFA Global X S&P Catholic Val.. 0.00 % 0.00 %

-0.05 (-3.08%)

USD 0.02B
ESIH:LSE iShares MSCI Europe Healt.. 0.00 % 0.00 %

-0.16 (-3.08%)

USD 0.81B
ESIH:F Ishares VI PLC - Ishares .. 0.00 % 0.00 %

N/A

N/A
ESIH:XETRA iShares MSCI Europe Healt.. 0.00 % 0.00 %

-0.18 (-3.08%)

N/A
CHDIV:SW UBS ETF (CH) - MSCI Switz.. 0.00 % 0.00 %

-0.33 (-3.08%)

USD 1,244,681.59B
S2HGBD:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.07B
SWEUAH:SW UBS ETF (CH) – MSCI Swi.. 0.00 % 0.00 %

N/A

USD 226,274.20B
S2HGBA:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 8.91M

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.02% 89% A- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.02% 89% A- 82% B
Trailing 12 Months  
Capital Gain 1.16% 74% C 51% F
Dividend Return 0.30% 30% F 3% F
Total Return 1.46% 74% C 38% F
Trailing 5 Years  
Capital Gain 76.85% 94% A 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 76.85% 94% A 56% F
Average Annual (5 Year Horizon)  
Capital Gain 11.61% 84% B 68% D+
Dividend Return 11.88% 84% B 63% D
Total Return 0.27% 30% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 17.31% 89% A- 61% D-
Risk Adjusted Return 68.65% 100% F 79% B-
Market Capitalization 46.01B 93% A 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.